PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders
2024-11-08
(Press-News.org)

Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver disease (ALD), and hepatitis C virus infection. These conditions are closely tied to hepatic steatosis, a condition characterized by the abnormal accumulation of fat in the liver. Recent genome-wide association studies have identified the 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) gene and its loss-of-function variant rs72613567, as a significant protective factor against CLD progression, particularly in MASH and ALD. The review highlights the importance of understanding this gene's function to unravel new therapeutic targets.

Role of HSD17B13 in Liver Disease

HSD17B13, primarily expressed in the liver, is associated with lipid metabolism within hepatic lipid droplets (LDs). The enzyme belongs to a family of proteins that regulate steroid hormone activity and lipid processing. Despite its structural similarities with other dehydrogenases, HSD17B13's primary function lies in modulating liver lipid metabolism. Importantly, the gene is linked to hepatocyte lipid accumulation and, by extension, to conditions like hepatic steatosis. Its loss-of-function mutation, rs72613567, results in a truncated, inactive protein that appears to protect against liver fat buildup and fibrosis, marking it as a key protective factor in CLD.

Genetic Interaction and Disease Progression

The review explores how HSD17B13 variants interact with other genetic factors, such as the PNPLA3 rs738409 mutation, known to elevate CLD risk. Research suggests that the HSD17B13 rs72613567 variant may mitigate the harmful effects of PNPLA3 mutations in liver fibrosis and even reduce the risk of hepatocellular carcinoma (HCC), particularly in MASH and ALD patients. Understanding these genetic interactions provides critical insights into the molecular mechanisms underlying liver disease progression and highlights the complex genetic landscape that modulates disease outcomes.

Protective Effects of HSD17B13 Variants

Several studies reviewed in the article confirm that individuals with the HSD17B13 rs72613567

variant exhibit a reduced risk for both MASH and ALD. For instance, the variant is linked to decreased liver inflammation, lower liver enzyme levels, and reduced progression to cirrhosis and HCC. Interestingly, the protective effects of the variant seem to be more pronounced in populations with traditional risk factors like obesity and alcohol consumption, further suggesting that HSD17B13 modulation may provide significant clinical benefits.

Implications for Hepatocellular Carcinoma (HCC)

The review delves into the potential role of HSD17B13 in the development of HCC. Studies have demonstrated that lower levels of HSD17B13 expression are associated with poor HCC outcomes. The gene's downregulation in liver cancer tissues contrasts with its protective effects in chronic liver conditions, suggesting a complex and context-dependent role in liver disease. The presence of the HSD17B13 variant correlates with better survival rates and reduced HCC incidence, emphasizing its potential utility in predictive genetic models for cancer risk.

Therapeutic Potential

The inhibition of HSD17B13, particularly in patients with metabolic liver disease, represents a promising therapeutic avenue. The article discusses ongoing research into RNA interference and small molecule inhibitors targeting HSD17B13, both of which have shown potential in reducing liver damage markers in experimental models. This approach could lead to the development of new treatments for MASH and ALD, particularly for individuals carrying the protective genetic variant.

Conclusions

This review underscores the significant role that HSD17B13 and its genetic variants play in CLD progression and protection. By reducing hepatic lipid accumulation and inflammation, the HSD17B13 rs72613567 variant offers a protective effect against liver fibrosis and HCC. Future research should focus on fully elucidating the molecular mechanisms behind these protective effects, with the goal of developing targeted therapies that could mitigate the global burden of CLD.

 

Full text

https://www.xiahepublishing.com/2310-8819/JCTH-2024-00257

 

The study was recently published in the Journal of Clinical and Translational Hepatology.

The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

END


[Attachments] See images for this press release:
Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders 2

ELSE PRESS RELEASES FROM THIS DATE:

Key pathway leading to neurodegeneration in early stages of ALS identified

Key pathway leading to neurodegeneration in early stages of ALS identified
2024-11-08
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for Disease Control and Prevention. The rapidly progressing neurodegenerative disease causes the death of neurons in the brain and spinal cord, resulting in muscle weakness, respiratory failure and dementia. Despite the devastating nature of the disease, little is known about what first triggers the deterioration of motor neurons at the onset of ALS. Now, researchers from University of California San Diego and their colleagues ...

Ferroptosis in regulating treatment tolerance of digestive system tumors

Ferroptosis in regulating treatment tolerance of digestive system tumors
2024-11-08
The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant tumors worldwide. Despite advancements in endoscopic diagnostic methods, which enable earlier detection and treatment, a large portion of patients still receive diagnoses at later stages. For these patients, chemotherapy, radiation, and immunotherapies are often the only viable options, yet resistance to treatment remains common, leading to high recurrence and mortality rates. Research increasingly shows that ferroptosis may be a key mechanism to reverse treatment tolerance. Ferroptosis, characterized by ...

A promising future in pancreatic incidentaloma detection

A promising future in pancreatic incidentaloma detection
2024-11-08
In recent research published in eGastroenterology, Dr. J-Matthias Löhr and colleagues provide an in-depth review of diagnostic methods for pancreatic incidentaloma—incidental findings often detected during imaging scans intended for other conditions. These pancreatic lesions, which vary in severity, can occasionally signal pancreatic cancer in its earliest stages. However, traditional methods, including MRI and CT scans, are limited by invasiveness, cost, and variable sensitivity to early pancreatic changes. The research highlights ...

Stabilizing lithium-ion batteries: The vanadium touch

Stabilizing lithium-ion batteries: The vanadium touch
2024-11-08
As demand surges for electric vehicles and energy storage systems, lithium-ion batteries need to deliver higher energy densities at lower costs. While conventional cathode materials like LiFePO4 and Li-Ni-Co-Mn-O are widely used, they often fail to balance performance with affordability. Lithium-rich manganese oxides (LRMOs) have emerged as a potential alternative due to their high capacity and cobalt-free composition. However, their low initial Coulombic efficiency and rapid voltage decay have limited their broader application. Addressing these challenges requires deeper research to stabilize LRMOs for widespread commercial use. In September, 2024, a team from Guangdong University of Technology, ...

Innovative approaches to the surgical challenges in the management of gastroschisis

Innovative approaches to the surgical challenges in the management of gastroschisis
2024-11-08
Gastroschisis, a congenital abdominal wall defect, has transformed from a uniformly fatal condition to one with a 95% survival rate through surgical advancements over the past six decades. The primary goal of managing gastroschisis is to mitigate fetal and postnatal risks, including damage from herniated bowel loops and ensuring effective decompression of the gastrointestinal tract during recovery. This review focuses on both preventative and corrective aspects of gastroschisis management, highlighting innovations in neonatal surgery that improve quality of life and long-term health outcomes. Definition ...

Mouse models for the study of liver fibrosis regression in vivo and ex vivo

Mouse models for the study of liver fibrosis regression in vivo and ex vivo
2024-11-08
Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be caused by a variety of factors, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol abuse, and viral hepatitis. MASLD affects a significant portion of the global population and can progress to metabolic dysfunction-associated steatohepatitis (MASH), leading to liver cirrhosis if left untreated. Given the prevalence of MASLD and its related conditions, the study of fibrosis and its regression ...

At Fortune Global Forum 2024, Alex Zhavoronkov PhD, Founder and CEO of Insilico Medicine, discusses AI business potential

At Fortune Global Forum 2024, Alex Zhavoronkov PhD, Founder and CEO of Insilico Medicine, discusses AI business potential
2024-11-08
From November 11 to 12, the Fortune Global Forum 2024, an invite-only premier event of Fortune, is set to gathers the leaders of the world’s biggest multinational companies on the dynamic frontiers of global business in New York, where business leaders from around the globe come together to create a modern roadmap for success. Insilico Medicine(“Insilico”), a global leading generative artificial intelligence (AI)-driven biotechnology company, announces that Alex Zhavoronkov PhD, founder and CEO of Insilico Medicine will be attending the Fortune ...

Exploring circulating tumor cells: Detection methods and biomarkers for clinical evaluation in hepatocellular carcinoma

Exploring circulating tumor cells: Detection methods and biomarkers for clinical evaluation in hepatocellular carcinoma
2024-11-08
Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence and mortality. Despite medical advancements, the late-stage diagnosis of HCC remains a major challenge, which underscores the need for more effective early detection strategies. Circulating tumor cells (CTCs), which are tumor cells released into the bloodstream from primary neoplastic sites, offer a promising avenue for non-invasive cancer diagnostics. This review provides a comprehensive overview of CTC detection methods, ...

New material to make next generation of electronics faster and more efficient

New material to make next generation of electronics faster and more efficient
2024-11-08
MINNEAPOLIS / ST. PAUL (11/08/2024) — Researchers at the University of Minnesota have achieved a new material that will be pivotal in making the next generation of high-power electronics faster, transparent and more efficient. This artificially designed material allows electrons to move faster while remaining transparent to both visible and ultraviolet light, breaking the previous record. The research, published in Science Advances, a peer-reviewed scientific journal, marks a significant leap forward in semiconductor ...

Research update: Chalk-coated textiles cool in urban environments

Research update: Chalk-coated textiles cool in urban environments
2024-11-08
As air temperatures stay elevated through fall months, people may still want clothes that cool them down while outside, especially if they live in cities that stay warmer than rural landscapes. Researchers who previously demonstrated a cooling fabric coating now report on additional tests of a treated polyester fabric in ACS Applied Materials & Interfaces. Fabric treated with the team’s chalk-based coating kept the air underneath up to 6 degrees Fahrenheit cooler in warmer urban environments. Researchers Evan D. Patamia, Megan K. Yee and Trisha L. ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders